Want to join the conversation?
Biopharmaceutical company $EBS said it expects 2015 revenue of $520-525MM, the midpoint of which represents 16% rise over 2014. This growth is driven by continued robust BioThrax sales, accounting for about $294MM. For 2015, $EBS expects GAAP EPS of $1.27-1.35, the midpoint of which represents 69% growth over 2014.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.
Impressed with $AMZN’s latest grocery ambitions. The new Amazon Go convenience store, is an absolute game changer.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$